학술논문
XTX301, a tumor-Activated Interleukin-12 has the potential to widen the therapeutic index of IL-12 treatment for solid tumors as evidenced by pre-clinical studies
Document Type
Article
Author
Patel, E.; Malkova, N.V.; Crowe, D.; Pederzoli-Ribeil, M.; Fantini, D.; Fanny, M.; Madala, H.R.; Jenkins, K.A.; Yerov, O.; Greene, J.; Guzman, W.; O'Toole, C.; Taylor, J.; Johnson, P.; Lanter, B.B.; Vu, S.; McLaughlin, M.; Hsiao, Y.-S.S.; Nicholson, B.; O'Neil, J.; Bialucha, C.U.; O'Donnell, R.K.; Ames, B.; Chen, J.; Wu, H.-J.; Cantin, S.; Tomar, D.S.; Rozenfeld, R.; Thiruneelakantapillai, L.; O'Hagan, R.C.
Source
In: Molecular Cancer Therapeutics . (Molecular Cancer Therapeutics, 1 April 2024, 23(4):421-435)
Subject
Language
English
ISSN
15388514
15357163
15357163